These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 35409260)

  • 1. Diet-Microbiota Interplay: An Emerging Player in Macrophage Plasticity and Intestinal Health.
    O'Mahony C; Amamou A; Ghosh S
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acids and lipid mediators in inflammatory bowel disease: from mechanism to treatment.
    Yan D; Ye S; He Y; Wang S; Xiao Y; Xiang X; Deng M; Luo W; Chen X; Wang X
    Front Immunol; 2023; 14():1286667. PubMed ID: 37868958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Dietary Nutrients in Inflammatory Bowel Disease.
    Sugihara K; Morhardt TL; Kamada N
    Front Immunol; 2018; 9():3183. PubMed ID: 30697218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talk between macrophages and gut microbiota in inflammatory bowel disease: a dynamic interplay influencing pathogenesis and therapy.
    Ning S; Zhang Z; Zhou C; Wang B; Liu Z; Feng B
    Front Med (Lausanne); 2024; 11():1457218. PubMed ID: 39355844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Relationship Between Gut Microbiota and Inflammatory Diseases: The Role of Macrophages.
    Wang J; Chen WD; Wang YD
    Front Microbiol; 2020; 11():1065. PubMed ID: 32582063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diet-Microbiota Interactions in Inflammatory Bowel Disease.
    Sugihara K; Kamada N
    Nutrients; 2021 May; 13(5):. PubMed ID: 34062869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
    Peng K; Xia S; Xiao S; Yu Q
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1710-1718. PubMed ID: 35906780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary Patterns and Gut Microbiota: The Crucial Actors in Inflammatory Bowel Disease.
    He P; Yu L; Tian F; Zhang H; Chen W; Zhai Q
    Adv Nutr; 2022 Oct; 13(5):1628-1651. PubMed ID: 35348593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
    Gasaly N; de Vos P; Hermoso MA
    Front Immunol; 2021; 12():658354. PubMed ID: 34122415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations among Dietary Omega-3 Polyunsaturated Fatty Acids, the Gut Microbiota, and Intestinal Immunity.
    Fu Y; Wang Y; Gao H; Li D; Jiang R; Ge L; Tong C; Xu K
    Mediators Inflamm; 2021; 2021():8879227. PubMed ID: 33488295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage immunometabolism in inflammatory bowel diseases: From pathogenesis to therapy.
    Pan X; Zhu Q; Pan LL; Sun J
    Pharmacol Ther; 2022 Oct; 238():108176. PubMed ID: 35346728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bases for the Adequate Development of Nutritional Recommendations for Patients with Inflammatory Bowel Disease.
    Sáez-González E; Mateos B; López-Muñoz P; Iborra M; Moret I; Nos P; Beltrán B
    Nutrients; 2019 May; 11(5):. PubMed ID: 31083616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk between hypoxia-inducible factor-1α and short-chain fatty acids in inflammatory bowel disease: key clues toward unraveling the mystery.
    Xiao J; Guo X; Wang Z
    Front Immunol; 2024; 15():1385907. PubMed ID: 38605960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Therapeutic Role of Short-Chain Fatty Acids Mediated Very Low-Calorie Ketogenic Diet-Gut Microbiota Relationships in Paediatric Inflammatory Bowel Diseases.
    Alsharairi NA
    Nutrients; 2022 Oct; 14(19):. PubMed ID: 36235765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics induce sustained dysregulation of intestinal T cell immunity by perturbing macrophage homeostasis.
    Scott NA; Andrusaite A; Andersen P; Lawson M; Alcon-Giner C; Leclaire C; Caim S; Le Gall G; Shaw T; Connolly JPR; Roe AJ; Wessel H; Bravo-Blas A; Thomson CA; Kästele V; Wang P; Peterson DA; Bancroft A; Li X; Grencis R; Mowat AM; Hall LJ; Travis MA; Milling SWF; Mann ER
    Sci Transl Med; 2018 Oct; 10(464):. PubMed ID: 30355800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage polarization in inflammatory bowel disease.
    Zhang K; Guo J; Yan W; Xu L
    Cell Commun Signal; 2023 Dec; 21(1):367. PubMed ID: 38129886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Potential Role for Gut Microbes in Mediating Effects of Omega-3 Fatty Acids in Inflammatory Bowel Diseases: A Comprehensive Review.
    Arjomand Fard N; Bording-Jorgensen M; Wine E
    Curr Microbiol; 2023 Oct; 80(11):363. PubMed ID: 37807005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short Chain Fatty Acids: Essential Weapons of Traditional Medicine in Treating Inflammatory Bowel Disease.
    Yao Y; Liu Y; Xu Q; Mao L
    Molecules; 2024 Jan; 29(2):. PubMed ID: 38257292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Omega-3 Fatty Acids on the Gut Microbiota.
    Costantini L; Molinari R; Farinon B; Merendino N
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29215589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory bowel disease is associated with increased gut-to-blood penetration of short-chain fatty acids: A new, non-invasive marker of a functional intestinal lesion.
    Jaworska K; Konop M; Bielinska K; Hutsch T; Dziekiewicz M; Banaszkiewicz A; Ufnal M
    Exp Physiol; 2019 Aug; 104(8):1226-1236. PubMed ID: 31243807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.